Clinical Trial Update: Management of LDL-cholesterol With Inclisiran + Usual Care Compared to Usual Care Alone in Participants With a Recent Acute Coronary Syndrome [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating whether adding inclisiran to usual care reduces LDL-cholesterol in patients with a recent acute coronary syndrome; results have been …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Drugs mentioned

• Inclisiran (inclisiran)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Acute Coronary Syndrome | Phase 3 | Status: COMPLETED | Results posted: 2025-08-21